Ying Fei Li

Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery

Daniel J. Siegwart, Kathryn A. Whitehead, Lutz Nuhn et al. · Proceedings of the National Academy of Sciences · 2011 · 201 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

A Phase I Study of CC-90002, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory (R/R) Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS): Final Results

Amer M. Zeidan, Daniel J. DeAngelo, Jeanne Palmer et al. · Blood · 2019 · 51 citations

Medicine, Hematology, Oncology +17

Anti-CD47 Antibody, CC-90002, in Combination with Rituximab in Subjects with Relapsed and/or Refractory Non-Hodgkin Lymphoma (R/R NHL)

Pau Abrisqueta, Juan‐Manuel Sancho, Raúl Córdoba et al. · Blood · 2019 · 36 citations

Life Sciences, Immunology, Pharmacotherapy +14

Exposure–Efficacy Analysis of Asciminib in Philadelphia Chromosome–Positive Chronic Myeloid Leukemia in Chronic Phase

François Pierre Combes, Ying Fei Li, Matthias Hoch et al. · Clinical Pharmacology & Therapeutics · 2022 · 34 citations

Medicine, Pharmacokinetics, Pharmacology +13

Population Pharmacokinetics of Asciminib in Tyrosine Kinase Inhibitor-Treated Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic and Acute Phases

Ying Fei Li, François Pierre Combes, Matthias Hoch et al. · Clinical Pharmacokinetics · 2022 · 22 citations

Medicine, Oncology, Pharmacokinetics +14